Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide

Overview of attention for article published in Cancer Research, December 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 1 X user
patent: 2 patents

wikipedia: 2 Wikipedia pages

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,463 followers.

@BijoyTelivala @AaronGoodman33 @Dr_AmerZeidan @MediHumdani @GunjanLShah @satya_yadav What we do need are clinical trials studying arsenic +/- atra for EVI1 rearranged leukemias. In vitro data showing that arsenic degrades evi1 protein. See https://t.co/…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.